Table II.
Subgroup of CD | Elafin [ng/ml] | Cathelicidin [ng/ml] | α1–3-defensins [ng/ml] | β1-defensin [pg/ml] |
---|---|---|---|---|
Inflammatory (B1) | 15.6 (11.6–50.1)* | 733 (429.3–1102.9)* | 387 (275.1–728.5)* | 201.9 (150.3–281.1) |
Stricturing (B2) | 9.8 (6.5–21.8) | 400 (293.9–721.8) | 218 (182.9–246.9) | 167.5 (131.9–190.4) |
Penetrating (B3) | 1.46 (1.21–11.4) | 323 (142.3–480.2) | 243 (196.2–529.1) | 152.7 (115.2–161.4) |
Controls | 9.8 (7.1–11.8) | 198.2 (162.9–231.9) | 256.4 (192.6–326.6) | 126.5 (94.6–139.1) |
p < 0.05, when comparing inflammatory (B1) vs. stricturing (B2) and penetrating (B3) lesions and controls.